Medical Condition News

RSS

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

Acton Pharmaceuticals, Inc. today announced that it has submitted to the U.S. Food and Drug Administration (FDA), a Manufacturing Supplement to the previously approved AEROSPAN Inhalation Aerosol NDA.

4 Nov 2010

New simple blood test may help diagnose Niemann-Pick type C disease

A fatal genetic disorder that frequently takes years to diagnose may soon be detectable with a simple blood test, researchers at Washington University School of Medicine in St. Louis and the National Institutes of Health (NIH) report this week in Simple blood test may diagnose deadly Niemann-Pick type C disease.

4 Nov 2010

Cerebral palsy risk doubles with IVF: Study

There is now evidence that rates of cerebral palsy are higher among children born via in vitro fertilization (IVF). There has been speculation that the parents’ infertility could be a reason but this new study is the first that links the procedure to the condition.

3 Nov 2010

Collapsing with laughter: Literally

Dr. Claire Allen, 35, suffers from rare and severe form of sleeping sickness that makes her pass out 100 times in a day. She is a research scientist at the British Antarctic Survey and she said that she has suffered from cataplexy, a severe form of narcolepsy that sees her lose control of her body and collapse into a deep sleep – although she remains conscious throughout.

3 Nov 2010

Workers unwilling to disclose work related stress: Survey

According to findings from a survey by mental health charity Mind, millions of British workers have lied to their bosses about taking sick leave when they feel overwhelmed by stress. The survey showed that one in five workers (19%) have taken stress-induced sick leave, but virtually all of them (93%) say they have lied to their boss about the real reason for not turning up. The usual reasons cited are stomach upsets, housing problems or even have a sick relative, rather than admitting the truth.

3 Nov 2010

Eye implant restores some vision in retinitis pigmentosa

According to a new scientific breakthrough, a device - a tiny, three-by-three millimetre microchip, has allowed patients with inherited blindness to detect objects with their eyes, unlike a rival approach that uses an external camera. The procedure details are outlined in the journal Proceedings of the Royal Society B.

3 Nov 2010

Bortezomib reduces inflammation and promotes bone healing in arthritis models

A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

3 Nov 2010

ADVENTRX submits NDA for Exelbine to FDA

ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion), or Exelbine.

3 Nov 2010

GTx receives $1.2 million under QTDP program

GTx, Inc. announced that the company has been awarded approximately $1.2 million by the United States Government under the Qualifying Therapeutic Discovery Project Program (QTDP), a $1 billion fund established under HR: 3590 Patient Protection and Affordable Care Act.

3 Nov 2010

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.

3 Nov 2010

IDEV receives FDA marketing clearance for SUPERA VERITAS Transhepatic Biliary System

IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS Transhepatic Biliary System.

3 Nov 2010

QLT third quarter sales decreases 12.9% to $20.5 million

QLT Inc. today reported financial results for the third quarter ended September 30, 2010. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. GAAP.

3 Nov 2010

InVivo receives $244,000 in grant funding under QTDP program

InVivo Therapeutics a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has been awarded $244,000 in grant funding as part of the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.

3 Nov 2010

Radiation oncologist says radiation quality assurance practices need to be standardized

In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.

3 Nov 2010

Deloitte releases new report on innovative strategies for oncology drug development

Deloitte released a new report, "Innovative Strategies for Oncology Drug Development," highlighting specific drug development approaches that have enabled biotech companies to produce a substantial number of first-in-class compounds and more than $1 billion in oncology drugs while transforming the medical outlook for many cancer patients.

3 Nov 2010

Lifestyle changes and natural supplements can control blood sugar levels

The holiday season can make it challenging for people with diabetes to keep their blood sugar levels stable. Diabetes expert, Dr. Isaac Eliaz recommends prevention through a number of lifestyle changes and natural supplements.

3 Nov 2010

APS summit focuses on Antiphospholipid Syndrome research

Antiphospholipid Syndrome (APS) is a condition that may be responsible for up to one-third of strokes in people under age 50, up to one-fifth of all cases of blood clots in large veins, and one-quarter of recurrent miscarriages. Nonetheless, relatively few randomized clinical trials have been conducted involving people with APS, and those completed have included small numbers of participants.

3 Nov 2010

Incyte announces achievement of $50 million in INCB18424 clinical trial

Incyte Corporation announced today the achievement of $50 million in milestones as part of the Incyte-Novartis collaboration and license agreement for INCB18424.

3 Nov 2010

Integra launches XKnife 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software

Integra LifeSciences Holdings Corporation announced today the launch of its XKnife® 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software. The XKnife® 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software is part of Integra's XKnife® System and is indicated for Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT).

3 Nov 2010

Labor-HHS bill to provide 3.2% increase in fiscal year 2011 for NIH

Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.

3 Nov 2010